JVT

Enabling Efficiency, Cost Reduction and Compliance Using a Validation Lifecycle Management System

Validation is a critical regulatory requirement for the Pharmaceutical industry. Validation is an important element of the 3-stage lifecycle approach described in the FDA Process Validation guidance document published in January 2011. The 3-stage approach includes Stage I Process Design, Stage 2 Qualification and Stage 3 Continued Process Verification. The lifecycle approach promotes the integration of the 3-stages where information and data are readily available during the entire process. The data generated during the entire lifecycle can be used to reduce the amount of validation and revalidation activities.

During the validation process companies generate a significant amount of data and information related to the lifecycle of GMP regulated systems. The traditional validation process is executed using paper-based records such as Validation Plans, System Specifications, Risk Assessments, Protocols and Validation Summary Reports. During the lifecycle of GMP systems a significant amount of paper-based records is generated that require storage and archival. Unfortunately, the cost of document storage and archival is very high during the entire lifecycle. The traditional validation process is quite inefficient and cost effective due the significant amount of inefficiencies related to manual activities such as printing, scanning, executing, and routing documents for review and approval.

This whitepaper summarizes the challenges found in the traditional validation process and the benefits achieved by implementing Validation Lifecycle Management Systems (VLMS). 

Instantly Download this Exclusive Whitepaper




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.

Comments (1)

Dear Ivan,

You write: "Validation is an important element of the 3-stage lifecycle approach described in the FDA Process Validation guidance document published in January 2011."  My understanding of the FDA's document is that the three stages together, the addition of the theee, must be considered "Validation". Thus, validation cannnot be an element of the 3-stage approach. A single element cannot be the whole. You continue by writing: "The 3-stage approach includes Stage I Process Design, Stage 2 Qualification and Stage 3 Continued Process  Verification." Correct; but in contradiction with your first sentence. Validation is not one of the three stages.

Best regards,

Michel

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.
Image CAPTCHA
Enter the characters shown in the image.